AAP 2022 Neonatal Hyperbilirubinemia

Operational access to the 2022 AAP phototherapy and exchange-transfusion thresholds through PediTools.

What is AAP 2022 Neonatal Hyperbilirubinemia?

AAP 2022 Neonatal Hyperbilirubinemia: Operational access to the 2022 AAP phototherapy and exchange-transfusion thresholds through PediTools. Population: Newb…

Population and scope

Neonatal Jaundice. Newborn infants 35 or more weeks of gestation

Also searched as

AAP Bili 2022 · aap 2022 bilirubin · neonatal hyperbilirubinemia · phototherapy threshold · newborn jaundice · aap 2022 bilirrubina · hiperbilirrubinemia neonatal · fototerapia

Clinical use

This PedsCore page brings together clinical information, implementation status and available evidence for AAP 2022 Neonatal Hyperbilirubinemia. It is intended for Newborn infants 35 or more weeks of gestation. The tool belongs to Neonatology and should be interpreted in the appropriate clinical context.

Interpretation and validation

Active tool based on the 2022 AAP guideline for newborn infants 35 or more weeks of gestation. PedsCore does not locally reproduce the AAP threshold curves or tables: it collects the clinical parameters and delegates operational threshold calculation to the free PediTools API implementing the guideline. Gestational age is entered in completed weeks (35-40+), postnatal age in hours (1-336), and bilirubin as TSB in mg/dL. Neurotoxicity risk factors in addition to gestational age include albumin <3 g/dL, isoimmune hemolytic disease/G6PD deficiency or other hemolysis, sepsis, or significant clinical instability in the previous 24 h. Do not subtract direct/conjugated bilirubin from TSB.

PedsCore does not replace clinical judgement. Scores, rules and calculators are presented with evidence traceability and a visible implementation status.

Clinical review and maintenance

Implementation review and independent clinical review are shown separately. PedsCore does not attribute named reviewers or external endorsement without a public record supporting the claim. The repository preserves source, change and test history.

Editorial transparency

This page is part of an open-source project. Evidence level, implementation status, validation notes and sources are shown explicitly. It currently contains 2 catalog references. Content and calculation changes are reviewed through the public repository, automated tests and version traceability.

The absence of an active calculator is not a clinical recommendation: some tools remain reference-only while source, licensing, exact variant or validation still require review.

Each page lets you verify what is being assessed, which population the tool describes, whether local calculation is available, which limitations remain open and which references support implementation. This context matters when different publications, versions or adaptations share a similar name but are not interchangeable.